Welcome to
the HerpeSelect® Website
The information in this site is organized by your interest in herpes
as a Patient, Healthcare Provider or Laboratory Professional. Each
section is hosted by a professional with extensive experience in
his or her field:
Patient Host: Terri Warren, RN, MS, ANP
Healthcare Provider Host: Gary A. Richwald, MD, MPH
Laboratory Professional Host: Wayne Hogrefe,
PhD
Making the Right Choices Requires
the Right Information
Patients, Healthcare Providers and Laboratory Professionals all
need the right information to make the right choices for diagnosing,
treating, and living with the herpes simplex virus (HSV) – as
well as preventing its transmission. Most herpes infections are
transmitted by people who are unaware they are infected with
the virus.
The Right Information
- Prevalence
- 22% of the adult US population is infected with HSV type-2.
(1)
- 25.5% of women are infected vs. 17.8% of men.
- 60 million people in the USA are infected with HSV type-2;
90% don’t know they have it.
- Viral shedding can transmit infection in the absence
of symptoms.
- About 70% of people get herpes from a partner who is
unaware
they have active herpes at the time they transmit the disease.
(2)
- HSV type-2 infection doubles the risk of acquiring HIV.
(3)
- African Americans have roughly three times the rate of
infection
as whites (46% vs. 17%.)
- Diagnosis
- Viral culture is the test most commonly used to diagnose
genital herpes, yet up to 70% of all cultures are falsely
negative in recurrent episodes.
- Up to 90% of all HSV type-2 infections go unnoticed or
undiagnosed. (1) Type-specific blood tests are essential
to detect asymptomatic or unrecognized infection.
- Treatment
- Treatment is available that can minimize or prevent outbreaks.
Severity and frequency of outbreaks may vary if infected
with HSV type-1 and/or HSV type-2 and can play a role in determining
treatment options.
The Right Choice
Individuals/Patients who have been sexually
active with multiple partners should be tested for HSV infection,
whether they have symptoms or not, in order to prevent the transmission
of HSV to their partner or potentially, to their unborn child.
With new information now available about the increased risk of
HIV infection with HSV type-2, it is even more important to test individuals
who are sexually active.
Healthcare Providers should request type-specific
serology tests to provide their patients with an accurate diagnosis
and appropriate lifestyle counseling.
Laboratory Professionals should offer FDA-cleared,
gG based type-specific serology tests for the accurate differentiation
of HSV type-1 and HSV type-2 infection.
(1) Flemming
DT, McQuillan GM, Johnson RE, et al. Herpes simplex virus type-2
in the United States, 1976 to 1994. N Engl J Med. 1997;337:1105-1111.
(2) Mertz GJ et al. Transmission of genital
herpes in couples with one symptomatic and one asymptomatic partner:
a prospective study. J Infect Dis. 1988 Jun;157(6):1169-77.
(3) Corey, L. Clinical Tools for Preventing
Transmission of Genital Herpes. Medscape Infectious Diseases
6(1) 2004 |